Roberto Festa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Roberto Festa has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Silvestrini
Dipartimento di Scienze della Salute e della Vita, Università Europea di Roma, 00163 Rome, Italy
4 shared publications - Elisabetta Meucci
Institute of Biochemistry and Clinical Biochemistry, Catholic University of the Sacred Heart, Rome, Italy
4 shared publications - Alfredo Pontecorvi
Endocrinology Unit, Università Cattolica del Sacro Cuore, Largo Agostino Gemelli 8, 00168, Rome, Italy.
3 shared publications - Antonio Mancini
Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00136 Rome, Italy
2 shared publications - Gian Paolo Littarru
Istituto di Biochimica, Università Politecnica delle Marche, Ancona, Italy
2 shared publications - Luca Tiano
Department of Life and Environmental Sciences, Polytechnic University of Marche, 60131 Ancona, Italy
2 shared publications
Latest Publications
- Open Access
- 9 December 2013
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (12) , 23893-23909
Thyroid Hormones and Antioxidant Systems: Focus on Oxidative Stress in Cardiovascular and Pulmonary Diseases
In previous works we demonstrated an inverse correlation between plasma Coenzyme Q10 (CoQ10) and thyroid hormones; in fact, CoQ10 levels in hyperthyroid patients were found among the lowest detected in human diseases. On the contrary, CoQ10 is elevated in hypothyroid subjects, also in subclinical conditions, suggesting the usefulness of this index in assessing metabolic status in thyroid disorders. A Low-T3 syndrome is a condition observed in several chronic diseases: it is considered an adaptation mechanism, where there is a reduction in pro-hormone T4 conversion. Low T3-Syndrome is not usually considered to be corrected with replacement therapy. We review the role of thyroid hormones in regulation of antioxidant systems, also presenting data on total antioxidant capacity and Coenzyme Q10. Published studies suggest that oxidative stress could be involved in the clinical course of different heart diseases; our data could support the rationale of replacement therapy in low-T3 conditions.
- 9 December 2013
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (12) , 23893-23909
Open AccessThyroid Hormones and Antioxidant Systems: Focus on Oxidative Stress in Cardiovascular and Pulmonary Diseases
In previous works we demonstrated an inverse correlation between plasma Coenzyme Q10 (CoQ10) and thyroid hormones; in fact, CoQ10 levels in hyperthyroid patients were found among the lowest detected in human diseases. On the contrary, CoQ10 is elevated in hypothyroid subjects, also in subclinical conditions, suggesting the usefulness of this index in assessing metabolic status in thyroid disorders. A Low-T3 syndrome is a condition observed in several chronic diseases: it is considered an adaptation mechanism, where there is a reduction in pro-hormone T4 conversion. Low T3-Syndrome is not usually considered to be corrected with replacement therapy. We review the role of thyroid hormones in regulation of antioxidant systems, also presenting data on total antioxidant capacity and Coenzyme Q10. Published studies suggest that oxidative stress could be involved in the clinical course of different heart diseases; our data could support the rationale of replacement therapy in low-T3 conditions.
- 22 August 2013
- Published by Hindawi Limited in Andrologia
- Vol. 46 (7) , 805-807
Coenzyme Q10supplementation in infertile men with low-grade varicocele: an open, uncontrolled pilot study
Many conditions associated with male infertility are inducers of oxidative stress, including varicocele. Antioxidants, such as coenzyme Q10, may be useful in this case. To evaluate the antioxidant capacity of seminal plasma of infertile men with varicocele before and after an oral supplementation with coenzyme Q10 , 38 patients were recruited from a pilot clinical trial. A standard semen analysis was also performed at baseline and 3 months after an oral supplementation with exogenous coenzyme Q10 100 mg per die. Seminal plasma antioxidant capacity was measured using a spectroscopic method. Coenzyme Q10 therapy improved semen parameters and antioxidant status. This study highlights the importance of oxidative stress in the pathogenesis of male infertility, namely in varicocele, and strengthens the possibility of the usefulness of the antioxidant therapy
- 22 August 2013
- Published by Hindawi Limited in Andrologia
- Vol. 46 (7) , 805-807
Coenzyme Q10supplementation in infertile men with low-grade varicocele: an open, uncontrolled pilot study
Many conditions associated with male infertility are inducers of oxidative stress, including varicocele. Antioxidants, such as coenzyme Q10, may be useful in this case. To evaluate the antioxidant capacity of seminal plasma of infertile men with varicocele before and after an oral supplementation with coenzyme Q10 , 38 patients were recruited from a pilot clinical trial. A standard semen analysis was also performed at baseline and 3 months after an oral supplementation with exogenous coenzyme Q10 100 mg per die. Seminal plasma antioxidant capacity was measured using a spectroscopic method. Coenzyme Q10 therapy improved semen parameters and antioxidant status. This study highlights the importance of oxidative stress in the pathogenesis of male infertility, namely in varicocele, and strengthens the possibility of the usefulness of the antioxidant therapy
- 1 April 2013
- Published by Bioscientifica in Endocrine Abstracts
Oxidative stress in middle age males with osteoporosis: correlation of hormonal pattern and plasma total antioxidant capacity
Male idiopathic osteoporosis is an underestimated disease, despite its clinical and social importance. The biochemical mechanisms are still poorly understood even if the interaction between genetic factors and hormone environment (especially gonadal steroids and GH) plays a undoubtful role. In previous studies we demonstrated low plasma total antioxidant capacity (TAC) in hypogonadal patients. The aim of this study was to investigate oxidative stress as risk factor for bone fracture, and its relationships with endocrine milieu. We enrolled 31 male subjects (36–72 years), all affected by back pain/spine fracture as a consequence of trivial trauma and ten healthy controls (30–48 years). TAC was determined using a colorimetric assay, using the system H2O2-metmyoglobin as source of radicals and a chromogen (ABTS); the latency time (LAG) in the accumulation of ABTS.+, spectroscopically detectable, is proportional to antioxidants concentration. An endocrine evaluation including testosterone, estradiol, insulin, IGF1, PRL, FT3, FT4, TSH levels was also performed. Finally, bone mineral density was assessed by DEXA. Bone metabolic parameters were evaluated (PTH, vitamin D, osteocalcin, and β-cross laps). Statistical evaluation was performed using Mann–Whitney U test. The prevalence of IGF1 defects (52.8±15.28 ng/ml) was 5/31 (suggesting GH deficiency (GHD), confirmed by GHRH+arginine test). Hypogonadism (mean testosterone levels 2.03±0.46 ng/ml) was present in 4/31. The 22 patients left did not show alterations in the hormonal parameters studied. Despite mean levels of LAG were not different between patients and controls (72.7±8.5 vs 75.0±6.0 s), 12 out of 31 patients had low LAG levels (between 50 and 60 s) irrespective of hormonal milieu. Moreover, when considering parameters of bone metabolism we found significantly lower vitamin D levels in hypogonadal subjects, than in patients with GHD and patients with normal hormonal parameters (10.7±5.8 ng/ml vs 19.7±17.7 and 22.7±9.7 respectively). These preliminary data suggest a possible involvement of oxidative stress in unexplained fractures even if further investigations are needed to establish a possible correlation with anabolic hormones involved in bone metabolism. Low vitamin D levels could exert a worsening effect on osteoporosis in hypogonadal patients.
- 1 April 2013
- Published by Bioscientifica in Endocrine Abstracts
Oxidative stress in middle age males with osteoporosis: correlation of hormonal pattern and plasma total antioxidant capacity
Male idiopathic osteoporosis is an underestimated disease, despite its clinical and social importance. The biochemical mechanisms are still poorly understood even if the interaction between genetic factors and hormone environment (especially gonadal steroids and GH) plays a undoubtful role. In previous studies we demonstrated low plasma total antioxidant capacity (TAC) in hypogonadal patients. The aim of this study was to investigate oxidative stress as risk factor for bone fracture, and its relationships with endocrine milieu. We enrolled 31 male subjects (36–72 years), all affected by back pain/spine fracture as a consequence of trivial trauma and ten healthy controls (30–48 years). TAC was determined using a colorimetric assay, using the system H2O2-metmyoglobin as source of radicals and a chromogen (ABTS); the latency time (LAG) in the accumulation of ABTS.+, spectroscopically detectable, is proportional to antioxidants concentration. An endocrine evaluation including testosterone, estradiol, insulin, IGF1, PRL, FT3, FT4, TSH levels was also performed. Finally, bone mineral density was assessed by DEXA. Bone metabolic parameters were evaluated (PTH, vitamin D, osteocalcin, and β-cross laps). Statistical evaluation was performed using Mann–Whitney U test. The prevalence of IGF1 defects (52.8±15.28 ng/ml) was 5/31 (suggesting GH deficiency (GHD), confirmed by GHRH+arginine test). Hypogonadism (mean testosterone levels 2.03±0.46 ng/ml) was present in 4/31. The 22 patients left did not show alterations in the hormonal parameters studied. Despite mean levels of LAG were not different between patients and controls (72.7±8.5 vs 75.0±6.0 s), 12 out of 31 patients had low LAG levels (between 50 and 60 s) irrespective of hormonal milieu. Moreover, when considering parameters of bone metabolism we found significantly lower vitamin D levels in hypogonadal subjects, than in patients with GHD and patients with normal hormonal parameters (10.7±5.8 ng/ml vs 19.7±17.7 and 22.7±9.7 respectively). These preliminary data suggest a possible involvement of oxidative stress in unexplained fractures even if further investigations are needed to establish a possible correlation with anabolic hormones involved in bone metabolism. Low vitamin D levels could exert a worsening effect on osteoporosis in hypogonadal patients.
- 1 June 2012
- Published by Edizioni Minerva Medica in La Rivista Italiana della Medicina di Laboratorio
- Vol. 8 (2) , 71-83
Albumina glicata. Un indice di controllo glicemico da rivalutare
L’albumina è una proteina di notevole importanza nella fisiologia dell’organismo e alterazioni nella sua struttura e funzione possono avere rilevanti ripercussioni fisiopatologiche. è quanto accade in seguito a processi di glicossidazione che portano alla formazione dell’albumina glicata in concentrazioni elevate in caso di iperglicemia cronica o di picchi iperglicemici rilevanti. L’albumina glicata si presenta quindi non solo come un indice di controllo della malattia diabetica, ma anche come un vero e proprio fattore patogenetico. E in non poche e non poco importanti condizioni il suo utilizzo può risultare più vantaggioso della stessa emoglobina glicata. Tuttavia, a causa dei limiti iniziali di specificità delle tecniche impiegate per misurare genericamente le fruttosamine (l’insieme delle proteine glicate circolanti), e a causa del persistere di una certa confusione tra fruttosamina e albumina glicata, la determinazione di quest’ultima non ha goduto dello stesso successo dell’emoglobina glicata. In verità, con le metodiche più recenti la misurazione dell’albumina glicata nel plasma umano è divenuta sufficientemente precisa e accurata, nonchè semplice ed economica da eseguire. I risultati che stanno emergendo negli ultimi anni in merito ai progressi analitici e alle applicazioni cliniche dell’albumina glicata porteranno probabilmente nel prossimo futuro a una richiesta sempre maggiore, nell’ottica della crescente attenzione all’appropriatezza in laboratorio. Albumin is a protein of considerable importance in the physiology of the body, and changes in its structure and function may have relevant pathophysiological implications. Glycoxidation processes lead to the formation of high levels of glycated albumin in chronic hyperglycaemia and during hyperglycaemic peaks. Therefore, glycated albumin is not only an index of diabetes control, but is also a true pathogenic factor, and in many conditions its use may be more advantageous than glycated haemoglobin. However, because of the limited specificity of the earlier techniques used to measure fructosamine (a generic term referring to all glycated serum proteins, including glycated albumin, in blood serum), and the persistence of a certain confusion between fructosamine and glycated albumin, the determination of the latter has not achieved the same success as glycated haemoglobin. Indeed, with the latest methods, measuring glycated albumin in human plasma has become sufficiently precise and accurate, and is also simple and inexpensive. The advances in recent years in the analytical procedure and the clinical application of glycated albumin will probably lead to an increasing demand in the near future, particularly in view of the growing acknowledgment of its appropriateness in the laboratory.
- 1 June 2012
- Published by Edizioni Minerva Medica in La Rivista Italiana della Medicina di Laboratorio
- Vol. 8 (2) , 71-83
Albumina glicata. Un indice di controllo glicemico da rivalutare
L’albumina è una proteina di notevole importanza nella fisiologia dell’organismo e alterazioni nella sua struttura e funzione possono avere rilevanti ripercussioni fisiopatologiche. è quanto accade in seguito a processi di glicossidazione che portano alla formazione dell’albumina glicata in concentrazioni elevate in caso di iperglicemia cronica o di picchi iperglicemici rilevanti. L’albumina glicata si presenta quindi non solo come un indice di controllo della malattia diabetica, ma anche come un vero e proprio fattore patogenetico. E in non poche e non poco importanti condizioni il suo utilizzo può risultare più vantaggioso della stessa emoglobina glicata. Tuttavia, a causa dei limiti iniziali di specificità delle tecniche impiegate per misurare genericamente le fruttosamine (l’insieme delle proteine glicate circolanti), e a causa del persistere di una certa confusione tra fruttosamina e albumina glicata, la determinazione di quest’ultima non ha goduto dello stesso successo dell’emoglobina glicata. In verità, con le metodiche più recenti la misurazione dell’albumina glicata nel plasma umano è divenuta sufficientemente precisa e accurata, nonchè semplice ed economica da eseguire. I risultati che stanno emergendo negli ultimi anni in merito ai progressi analitici e alle applicazioni cliniche dell’albumina glicata porteranno probabilmente nel prossimo futuro a una richiesta sempre maggiore, nell’ottica della crescente attenzione all’appropriatezza in laboratorio. Albumin is a protein of considerable importance in the physiology of the body, and changes in its structure and function may have relevant pathophysiological implications. Glycoxidation processes lead to the formation of high levels of glycated albumin in chronic hyperglycaemia and during hyperglycaemic peaks. Therefore, glycated albumin is not only an index of diabetes control, but is also a true pathogenic factor, and in many conditions its use may be more advantageous than glycated haemoglobin. However, because of the limited specificity of the earlier techniques used to measure fructosamine (a generic term referring to all glycated serum proteins, including glycated albumin, in blood serum), and the persistence of a certain confusion between fructosamine and glycated albumin, the determination of the latter has not achieved the same success as glycated haemoglobin. Indeed, with the latest methods, measuring glycated albumin in human plasma has become sufficiently precise and accurate, and is also simple and inexpensive. The advances in recent years in the analytical procedure and the clinical application of glycated albumin will probably lead to an increasing demand in the near future, particularly in view of the growing acknowledgment of its appropriateness in the laboratory.
- 1 May 2012
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 14 (5) , 444-446
Time Is Glucose, Can't Miss Gestational Diabetes
Background: Gestational diabetes mellitus (GDM) is associated with adverse perinatal outcomes, if not treated. International guidelines recommend screening “all or high-risk women” at the initial prenatal visit, when a fasting plasma glucose (FPG) between 92 and 126 mg/dL is diagnostic for GDM. However, glucose testing may be affected by a great pre-analytical variability (usually overlooked), due to, for example, kind of sample (serum/plasma), temperature of storage, time between blood draw and centrifugation (in-tube glycolysis), and use of a glycolysis inhibitor. So GDM may be easily missed. We aimed to evaluate the potential characteristics of this important issue. Subjects and Methods: FPG was tested by both “routine” and “gold standard” protocols in 60 women at the first trimester of gestation, presenting for GDM screening. “Routine” blood plasma was collected in a tube with sodium fluoride, kept at room temperature, centrifuged, and tested 30–45 min after blood draw. “Gold standard” was a specimen from the same blood sample that was centrifuged within 5 min and tested together with the “routine” specimen. Results: In the “routine” protocol, 10 mg/dL on average was lost for each determination. Thirteen cases of GDM and two of overt diabetes (FPG >126 mg/dL) were missed in this preliminary series. Conclusions: The risk for GDM underdiagnosis in the first half of pregnancy appears to be actual and wide. A closer collaboration between clinicians and pathologists is critical, allowing a stricter adherence to the laboratory guidelines to be ensured.
- 1 May 2012
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 14 (5) , 444-446
Time Is Glucose, Can't Miss Gestational Diabetes
Background: Gestational diabetes mellitus (GDM) is associated with adverse perinatal outcomes, if not treated. International guidelines recommend screening “all or high-risk women” at the initial prenatal visit, when a fasting plasma glucose (FPG) between 92 and 126 mg/dL is diagnostic for GDM. However, glucose testing may be affected by a great pre-analytical variability (usually overlooked), due to, for example, kind of sample (serum/plasma), temperature of storage, time between blood draw and centrifugation (in-tube glycolysis), and use of a glycolysis inhibitor. So GDM may be easily missed. We aimed to evaluate the potential characteristics of this important issue. Subjects and Methods: FPG was tested by both “routine” and “gold standard” protocols in 60 women at the first trimester of gestation, presenting for GDM screening. “Routine” blood plasma was collected in a tube with sodium fluoride, kept at room temperature, centrifuged, and tested 30–45 min after blood draw. “Gold standard” was a specimen from the same blood sample that was centrifuged within 5 min and tested together with the “routine” specimen. Results: In the “routine” protocol, 10 mg/dL on average was lost for each determination. Thirteen cases of GDM and two of overt diabetes (FPG >126 mg/dL) were missed in this preliminary series. Conclusions: The risk for GDM underdiagnosis in the first half of pregnancy appears to be actual and wide. A closer collaboration between clinicians and pathologists is critical, allowing a stricter adherence to the laboratory guidelines to be ensured.
- Open Access
- 9 December 2011
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 12 (12) , 9216-9225
Hormonal Influence on Coenzyme Q10 Levels in Blood Plasma
Coenzyme Q10 (CoQ10), also known as ubiquinone for its presence in all body cells, is an essential part of the cell energy-producing system. However, it is also a powerful lipophilic antioxidant protecting lipoproteins and cell membranes. Due to these two actions, CoQ10 is commonly used in clinical practice in chronic heart failure, male infertility, and neurodegenerative disease. However, it is also taken as an anti-aging substance by healthy people aiming for long-term neuroprotection and by sportsmen to improve endurance. Many hormones are known to be involved in body energy regulation, in terms of production, consumption and dissipation, and their influence on CoQ10 body content or blood values may represent an important pathophysiological mechanism. We summarize the main findings of the literature about the link between hormonal systems and circulating CoQ10 levels. In particular the role of thyroid hormones, directly involved in the regulation of energy homeostasis, is discussed. There is also a link with gonadal and adrenal hormones, partially due to the common biosynthetic pathway with CoQ10, but also to the increased oxidative stress found in hypogonadism and hypoadrenalism.
- 9 December 2011
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 12 (12) , 9216-9225
Open AccessHormonal Influence on Coenzyme Q10 Levels in Blood Plasma
Coenzyme Q10 (CoQ10), also known as ubiquinone for its presence in all body cells, is an essential part of the cell energy-producing system. However, it is also a powerful lipophilic antioxidant protecting lipoproteins and cell membranes. Due to these two actions, CoQ10 is commonly used in clinical practice in chronic heart failure, male infertility, and neurodegenerative disease. However, it is also taken as an anti-aging substance by healthy people aiming for long-term neuroprotection and by sportsmen to improve endurance. Many hormones are known to be involved in body energy regulation, in terms of production, consumption and dissipation, and their influence on CoQ10 body content or blood values may represent an important pathophysiological mechanism. We summarize the main findings of the literature about the link between hormonal systems and circulating CoQ10 levels. In particular the role of thyroid hormones, directly involved in the regulation of energy homeostasis, is discussed. There is also a link with gonadal and adrenal hormones, partially due to the common biosynthetic pathway with CoQ10, but also to the increased oxidative stress found in hypogonadism and hypoadrenalism.
- 30 September 2009
- Published by Elsevier in Metabolism
- Vol. 58 (9) , 1367
Reply: Total antioxidant capacity after malabsorptive bariatric surgery
- 30 September 2009
- Published by Elsevier in Metabolism
- Vol. 58 (9) , 1367
Reply: Total antioxidant capacity after malabsorptive bariatric surgery